Document is current
Any future updates will be listed below
-
Authors
Kapadia, Akshay https://orcid.org/0000-0001-7173-4122
Schuhmann, Fabian https://orcid.org/0000-0002-3768-6494
Daskin, Ezgi https://orcid.org/0000-0001-6542-2608
Walter, Jochen
Lindahl, Isabell
Rahmani, Neda
Morrema, Tjado H J
Rozemuller, Annemieke J M https://orcid.org/0000-0003-2528-4428
Boon, Baayla D C https://orcid.org/0000-0002-4922-3286
Pezeshkian, Weria
Hafner, Anne-Sophie https://orcid.org/0000-0003-4416-7307
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (101076961)
KU | Novo Nordisk Foundation Center for Protein Research, University of Copenhagen (NNF18SA0035142 & NNF22OC0079182)
Independent Research Fund Denmark (https://doi.org/10.46540/2064-00032B)
Dr.phil Ragna Rask-Nielsens Grundforskningsfond
- License Information
-
More Information
Article History
Received: 10 February 2026
Revised: 12 July 2026
Accepted: 23 July 2026
First Online: 1 September 2026
Disclosure and competing interests statement
: The authors declare no competing interests. BDCB reports honoraria from F. Hoffmann-La Roche and serves as the Vice Chair of the Atypical Alzheimer’s Disease Professional Interest Area, organized by Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART).
